Joinn Laboratories (06127) cancelled 12.91 million shares of inventory stock on January 7th.
Zhao Yan New Drug (06127) announced that on January 7, 2026, it cancelled 129,100 shares of stock previously designated for the 2021 and 2022 A-share employee stock ownership plans.
Joinn Laboratories (06127) announced that on January 7, 2026, it will cancel 129,100 shares of common stock related to the 2021 and 2022 A-share employee stock ownership plans.
Related Articles
On January 8th, Dingdang Health (09886) spent HK $1.5677 million to repurchase 1.42 million shares.
CHAOJU EYE CARE (02219) spent 160,700 Hong Kong dollars on January 8 to repurchase 60,000 shares.
Blue Moon Group (06993): Use the minimum specified public shareholding level as a substitute for the threshold.
On January 8th, Dingdang Health (09886) spent HK $1.5677 million to repurchase 1.42 million shares.
CHAOJU EYE CARE (02219) spent 160,700 Hong Kong dollars on January 8 to repurchase 60,000 shares.
Blue Moon Group (06993): Use the minimum specified public shareholding level as a substitute for the threshold.
RECOMMEND
Bank Of America Sees Three Drivers Supporting Chinese Consumer Stocks: Low Base, Deep Undervaluation, And Convertible‑Like Defensive Traits
07/01/2026
Cross‑Border E‑Commerce In 2025: Tariffs, Trade Wars, And Shifting Away From The United States
07/01/2026
Asian Stock Markets Record The Strongest Annual Start Ever As Shanghai Composite Hits Multi‑Year High And Sets Longest Winning Streak; Japan And Korea Rally
07/01/2026
